hematologic malignancies
By Ruben A. Mesa, MD, and James O. Armitage, MD / 2015 ASCO Annual Meeting
James O. Armitage, MD, of The University of Nebraska Medical Center, and Ruben A. Mesa, MD, of the Mayo Clinic, discuss pacritinib and its significant efficacy in myelofibrosis (Abstract LBA7006).